Skip to main navigation
TCR2 Staging

Corporate Menu & Investor Relations

Contact Patients
Mission Leadership Community
The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications
Overview TC-210 TC-110 Pipeline
Press Releases In the News Awards
Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs
Careers
investors.jpg
TCR2 Investors

Corporate Menu & Investor Relations

About Us Mission Leadership Community Technology The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications Programs Overview TC-210 TC-110 Pipeline News Press Releases In the News Awards Investors Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs Careers Careers Contact Patients

Press Releases

Latest Press Releases | In The News

Press Releases

All News | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |

Nov 12, 2019

TCR² Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update


Oct 09, 2019

TCR² Therapeutics Appoints Industry Veteran Angela Justice, Ph.D., as Chief People Officer


Sep 27, 2019

TCR² Therapeutics to Present at the Cantor Global Healthcare Conference


Aug 30, 2019

TCR² Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference


Aug 08, 2019

TCR² Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update


Aug 06, 2019

TCR² Therapeutics to Participate in Upcoming Conferences in August


Aug 06, 2019

TCR² Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires


Jul 31, 2019

TCR² Therapeutics Announces Partnership with the National Cancer Institute for Phase 1/2 Trial of TC-210


Jun 28, 2019

TCR² Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes


May 13, 2019

TCR² Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update


Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »

Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR
TCR2
 

100 Binney Street, Suite 710
Cambridge, MA 02142
617.949.5200

TERMS OF USE

Corporate Menu & Investor Relations

About Us
Technology
Programs
News
Investors
Careers
Contact
Patients